MedPath
FDA Approval

Oxandrolone

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
March 7, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Oxandrolone(10 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Par Pharmaceutical Inc.

092733690

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Oxandrolone

Product Details

NDC Product Code
49884-302
Application Number
ANDA077827
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
July 5, 2023
Code: 7H6TM3CT4LClass: ACTIBQuantity: 10 mg in 1 1
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT

Oxandrolone

Product Details

NDC Product Code
49884-301
Application Number
ANDA077827
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
July 5, 2023
Code: 7H6TM3CT4LClass: ACTIBQuantity: 2.5 mg in 1 1
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath